Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 7/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | HTR2C | P28335 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | CTSV | O60911 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.48 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1875671 | 0.91 | NISCH (0.63) | MCHR1CYP3A4CTSVCTSLADRA2A | |
| SCHEMBL31153237 | 0.90 | MCHR1 (0.61) | MCHR1CYP3A4HTR2CHTR2ACTSV | |
| SCHEMBL25634129 | 0.90 | MCHR1 (0.61) | MCHR1CYP3A4HTR2CHTR2ACTSV | |
| SCHEMBL25634070 | 0.88 | MCHR1 (0.57) | MCHR1CYP3A4HTR2CHTR2ACTSV | |
| SCHEMBL12927682 | 0.83 | MCHR1 (1.00) | MCHR1CYP3A4 | |
| Hydrochloric Acid SCHEMBL1005571 | 0.82 | MCHR1 (0.98) | MCHR1CYP3A4 | |
| SCHEMBL25634007 | 0.82 | MCHR1 (0.61) | MCHR1CYP3A4CTSVCTSLMAOA | |
| SCHEMBL25634072 | 0.82 | HTR2A (0.59) | MCHR1CYP3A4HTR2CHTR2AADRA2A | |
| SCHEMBL2978779 | 0.81 | LMNA (0.63) | MCHR1CYP3A4CTSVCTSLADRA2A | |
| SCHEMBL25189080 | 0.77 | HTR7 (0.81) | MCHR1CYP3A4HTR2CHTR2AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2025-07-24 | — | — | US | disclosed |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | DELIX THERAPEUTICS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2023114313-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335454-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | MCHR1 633/4885CYP3A4 4129/4885HTR2C 88/4885 |
| US-12295959-B2 | Phenoxy and benzyloxy substituted psychoplastogens and uses thereof | GAP43, BDNF, GRIN2A | MCHR1 633/4885CYP3A4 4129/4885HTR2C 88/4885 |
| US-20250235463-A1 | PHENOXY AND BENZYLOXY SUBSTITUTED PSYCHOPLASTOGENS AND USES THEREOF | GAP43, BDNF, GRIN2A | MCHR1 633/4885CYP3A4 4129/4885HTR2C 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.